Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard questions: Can we take gepants like Nurtec or Ubrelvy…
The National Headache Foundation (NHF) welcomed 21 new healthcare providers who passed the recent certification exam for its Certificate of Added Qualification in Headache Medicine (AQH) program. Tom Dabertin, NHF chief executive officer and executive director, said “the September graduates have fully mastered the standards…
Headache Heroes 2021 Patient: Evie Mohan Advocate: Katie MacDonald Caregiver: Chris Charrett-Dykes Healthcare Provider: Jaclyn Duvall, MD, AQH Congratulations to the four Headache Heroes winners who were selected from the many nominations submitted by the public. The winners were honored at the National Headache Foundation’s…
The U.S. Food and Drug Administration (FDA) approved QULIPTA™ (atogepant) for the preventive treatment of episodic migraine in adults. QULIPTA is the first and only oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) specifically developed for the preventive treatment of migraine disease. The approval is…
The National Headache Foundation (NHF) launched Primary Care Migraine, a new educational training program available at no cost to health practitioners. The program was announced by Tom Dabertin, Executive Director and Chief Executive Officer of the National Headache Foundation. “NHF seeks to offer cutting-edge educational…
Idell Applebaum September 23, 1923 – September 18, 2021 Idell Applebaum was born in Chicago on September 23, 1923, to the late Rose (Roth) and Nathan Diamond. She was preceded in death by her siblings: Alfred Diamond, MD (Georgiene), Ann Diamond, and Seymour Diamond, MD…
Country music star Allie Sealey will perform at the National Headache Foundation (NHF) Gala on Oct. 2 at the Langham Hotel, including her award-winning song, “Not All in Our Heads.” California-born Sealey earned an award for her song that resonates with those who experience migraines…
Dr. Lindsay Weitzel talks to Dr. Tim Smith about the specifics of Trudhesa, the first DHE nasal spray to utilize Precision Olfactory Delivery (POD) technology. Trudhesa was just approved by the FDA. When will it be available to us? How soon do we have to…
The NHF selection committee had the difficult task of choosing four winners from the outstanding pool of nominees submitted by the public. The four winners exemplify the spirit of the Headache Hero award and go above and beyond to raise awareness, advocacy, and care for…
Practitioners Who Care for Patients with Migraine Diseases and Headache Disorders Should Review Updated Qualifications and Register by Aug. 23 The National Headache Foundation (NHF) has announced its Fall certification exam for its Certificate of Added Qualification in Headache Medicine (AQH) program. The deadline for…
Subscribe to our Monthly e-Newsletter
Gain access to the most current migraine and headache information, prevention,
treatment, research, and news.
